T2 Biosystems Statistics

Total Valuation

T2 Biosystems has a market cap or net worth of $10.49 million. The enterprise value is $27.35 million.

Market Cap	10.49M
Enterprise Value	27.35M

Important Dates

The last earnings date was Thursday, November 14, 2024, after market close.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

T2 Biosystems has 20.56 million shares outstanding. The number of shares has increased by 659.51% in one year.

Current Share Class	20.56M
Shares Outstanding	20.56M
Shares Change (YoY)	+659.51%
Shares Change (QoQ)	+26.94%
Owned by Insiders (%)	4.97%
Owned by Institutions (%)	7.35%
Float	7.47M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.70
Forward PS	0.53
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	3.56
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.40

Current Ratio	0.40
Quick Ratio	0.17
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-13.07

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-84.85%
Return on Capital (ROIC)	-138.95%
Revenue Per Employee	$67,938
Profits Per Employee	-$380,124
Employee Count	113
Asset Turnover	0.25
Inventory Turnover	6.84

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -86.58% in the last 52 weeks. The beta is 0.38, so T2 Biosystems's price volatility has been lower than the market average.

Beta (5Y)	0.38
52-Week Price Change	-86.58%
50-Day Moving Average	1.31
200-Day Moving Average	3.54
Relative Strength Index (RSI)	24.94
Average Volume (20 Days)	926,455

Short Selling Information

The latest short interest is 834,762, so 4.06% of the outstanding shares have been sold short.

Short Interest	834,762
Short Previous Month	566,485
Short % of Shares Out	4.06%
Short % of Float	11.18%
Short Ratio (days to cover)	1.26

Income Statement

In the last 12 months, T2 Biosystems had revenue of $7.68 million and -$42.95 million in losses. Loss per share was -$4.08.

Revenue	7.68M
Gross Profit	-20.05M
Operating Income	-41.66M
Pretax Income	-48.26M
Net Income	-42.95M
EBITDA	-41.40M
EBIT	-41.66M
Loss Per Share	-$4.08

Full Income Statement

Balance Sheet

The company has $2.08 million in cash and $18.94 million in debt, giving a net cash position of -$16.86 million or -$0.82 per share.

Cash & Cash Equivalents	2.08M
Total Debt	18.94M
Net Cash	-16.86M
Net Cash Per Share	-$0.82
Equity (Book Value)	-11.71M
Book Value Per Share	-0.65
Working Capital	-14.65M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$36.59 million and capital expenditures -$26,000, giving a free cash flow of -$36.62 million.

Operating Cash Flow	-36.59M
Capital Expenditures	-26,000
Free Cash Flow	-36.62M
FCF Per Share	-$1.78

Full Cash Flow Statement

Margins

Gross Margin	-261.12%
Operating Margin	-542.59%
Pretax Margin	-559.52%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-611.00%

Dividends & Yields

T2 Biosystems does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-659.51%
Shareholder Yield	-659.51%
Earnings Yield	-409.59%
FCF Yield	-349.17%

Analyst Forecast

The average price target for T2 Biosystems is $5.00, which is 880.39% higher than the current price. The consensus rating is "Hold".

Price Target	$5.00
Price Target Difference	880.39%
Analyst Consensus	Hold
Analyst Count	1
Revenue Growth Forecast (5Y)	53.96%
EPS Growth Forecast (5Y)	-54.42%

Stock Forecasts

Stock Splits

The last stock split was on October 13, 2023. It was a reverse split with a ratio of 0.01:1.

Last Split Date	Oct 13, 2023
Split Type	Reverse
Split Ratio	0.01:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1